Feature | SCAI | May 14, 2018

SCAI 2018 Late-breaking Clinical Trials

Richard Schatz, M.D., (center) is research director of cardiovascular interventions at the Heart, Lung, and Vascular Center at Scripps Clinic, speaking at a SCAI session on collaboration with industry to bring new device technologies to market. He is best known as the co-inventor of the first coronary stent, the Palmaz-Schatz stent. Left is Ziyad Hijazi, M.D., MPH, director of the Sidra Cardiac Program. #SCAI, #SCAI2018

Richard Schatz, M.D., (center) research director of cardiovascular interventions at the Heart, Lung, and Vascular Center at Scripps Clinic, speaking at a 2018 SCAI session on collaboration with industry to bring new device technologies to market. He is best known as the co-inventor of the first coronary stent, the Palmaz-Schatz stent. Left is Ziyad Hijazi, M.D., MPH, director of the Sidra Cardiac Program, Sidra Medical and Research Center, Doha, Qatar, who has been active in new device technologies for structural heart disease.


Here is an aggregation of all the news and late-breaking studies presented at the 2018 Society for Cardiovascular Angiography and Interventions (SCAI) Scientific Sessions. 

 

Late-breaking Studies:

Derivation of a Simple Risk Tool to Predict 30-day Readmissions after Transcatheter Aortic Valve Replacement — Presented by Sahil Khera, M.D., Massachusetts General Hospital

Procedural, Clinical and Health Status Outcomes in Chronic Total Coronary Occlusion Revascularization with Zotarolimus-Eluting Stents: Results from the PERSPECTIVE Trial — Presented by David Kandzari, M.D., Piedmont Heart Institute

Length of Stay Post Trans-Femoral Transcatheter Aortic Valve Replacement — Presented by Siddharth Wayangankar, M.D., Shands/University of Florida

A Prospective, Single-Arm Multicenter Trial of Catheter-Directed Mechanical Thrombectomy for Intermediate-Risk Acute Pulmonary Embolism: The FLARE Study — Presented by Thomas Tu, M.D., Baptist Health Louisville

Immunomodulatory Therapy Reduces Atherosclerotic Plaque Burden by Coronary Computed Tomography Angiography in Psoriasis at One-Year — Presented by Nehal Mehta, M.D., National Heart, Lung, and Blood Institute

Culprit Vessel vs. Multivessel Revascularization Strategies in Acute Myocardial Infarction and Cardiogenic Shock: Insights from the British Columbia Cardiac Registry — Presented by Bilal Iqbal, M.D., Victoria Heart Institute Foundation, Canada

PROGRESS-CTO: The Hybrid Approach of Percutaneous Coronary Interventions for Chronic Total Occlusions — Presented by Peter Tajti, M.D., Abbott Northwestern Hospital

• The Abbott Post-Approval Study 1 MitraClip Registry: 1-year Results of the First 2,000 Patients in the Transcatheter Valve Therapy Registry — Presented by James Hermiller, M.D., The St. Vincent Medical Group at The Heart Center

Strategies to Reduce Acute Kidney Injury and Improve Clinical Outcomes After Percutaneous Coronary Intervention (PCI): A PRESERVE Trial Subgroup Analysis of the Prevention of Serious Adverse Events — Presented by Santiago Garcia, M.D., Minneapolis VA Medical Center

Discrepancy Between Physician Perception and Objective Assessment of Stroke, Stent Thrombosis and Bleeding Risk in Patients with Atrial Fibrillation Undergoing PCI: Results From the Aviator 2 International Registry — Presented by Roxana Mehran, M.D., Icahn School of Medicine at Mount Sinai

 

Other Key Presentations at SCAI:

More Patients Admitted With Cardiac Conditions in Winter Than Other Months

Intravenous Drug Use is Causing Rise in Heart Valve Infections, Healthcare Costs

3-D Printed Models to Guide TAVR Improve Outcomes

SCAI Launches Diagnosis and Treatment Toolkit for Peripheral Artery Disease

Medtronic Shares Two-Year Harmony Transcatheter Pulmonary Valve Results

SCAI Updates Consensus on Length of Stay for Percutaneous Coronary Intervention

SCAI Releases Consensus Guidelines for Femoral-Popliteal Arterial Interventional Device Selection

Follow other SCAI news

 

 

Other Late-breaking Cardiology Trials in 2018:

ACC 2018 Late-Breaking Trials

TCT 2018 Late-breaking Cardiovascular Clinical Trials

EuroPCR 2018 Late-breaking Trials in Interventional Cardiology

Heart Rhythm 2018 Late-breaking Studies

 

 

#SCAI2018  #SCAI18  #SCAI


Related Content

News | Cardiovascular Clinical Studies

January 26, 2023 — A newly-released study extends the understanding of how acquired mutations in blood cells act as a ...

Home January 26, 2023
Home
News | Cardiovascular Clinical Studies

January 24, 2023 — Four cardiology organizations have joined forces in a call to action to reinvent randomized clinical ...

Home January 24, 2023
Home
News | Cardiovascular Clinical Studies

January 11, 2023 — Imbria Pharmaceuticals, Inc., a clinical stage, cardiometabolic company developing novel therapies ...

Home January 11, 2023
Home
News | Cardiovascular Clinical Studies

January 3, 2023 — Acutus Medical, Inc., an arrhythmia management company focused on improving the way cardiac ...

Home January 03, 2023
Home
News | Cardiovascular Clinical Studies

December 30, 2022 — The Cardiovascular Research Foundation (CRF) recently announced that Alexandra Popma, MD, has joined ...

Home December 30, 2022
Home
News | Cardiovascular Clinical Studies

December 28 2022 — Abiomed announces the United States Food and Drug Administration (FDA) has approved the version of ...

Home December 28, 2022
Home
News | Cardiovascular Clinical Studies

December 27, 2022 — A groundbreaking new clinical trial to determine the effectiveness of a new treatment for patients ...

Home December 27, 2022
Home
News | Cardiovascular Clinical Studies

December 21, 2022 — Esperion announced that the landmark Cholesterol Lowering via Bempedoic acid, an ACL-Inhibiting ...

Home December 21, 2022
Home
News | Cardiovascular Clinical Studies

December 13, 2022 — A new study by researchers at Intermountain Healthcare in Salt Lake City finds that patients without ...

Home December 13, 2022
Home
News | Cardiovascular Clinical Studies

December 9, 2022 — BioSig Technologies, Inc. an advanced digital signal processing technology company delivering ...

Home December 09, 2022
Home
Subscribe Now